Ebola vaccine trial results ‘promising’

File photo

An experimental ebola vaccine has triggered promising immune responses from 20 healthy volunteers taking part in a preliminary trial.

The results suggest the vaccine should protect people against the deadly infection that has claimed more than 5,000 lives since March.

Scientists are now preparing for larger trials in West Africa next year that will show definitively whether or not the vaccine works.

The vaccine, co-developed by the drug company GlaxoSmithKline (GSK) and the US National Institutes of Health (NIH), contains pieces of genetic material from two strains of the virus.

It is delivered into the bloodstream by a chimpanzee version of the common cold virus that causes no illness to humans.

The Phase I safety trial in the US recruited 20 healthy volunteers between the ages of 18 and 50 who were given two different doses of the vaccine.

All of them developed ebola-targeting antibodies in their blood within four weeks of being treated. Antibody levels were greater in those given the higher dose.

In many of the volunteers the vaccine also generated CD8 “killer” T-cells — a type of immune system cell that attacks and destroys dangerous infected cells. These may also prove to be an important part of the immune response against ebola.

Dr Anthony Fauci, director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), said: “The unprecedented scale of the current ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines, which may play a role in bringing this epidemic to an end and undoubtedly will be critically important in preventing future large outbreaks.

“Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plans for larger trials to determine if the vaccine is efficacious in preventing ebola infection.”

The vaccine used in the trial is designed to protect against both the Sudan and Zaire strains of ebola. The current outbreak was caused by the Zaire strain.

Early trials of a “monovalent” version of the vaccine that only targets the Zaire strain are under way in Oxford, Mali and Switzerland.

The desperate need for a vaccine has seen rival pharmaceutical companies scrambling to be first with an effective treatment.

Merck has paid at least $30m (€24m) for the rights to another experimental vaccine, rVSV-EBOV, developed by NewLink Genetics.

The World Health Organisation has reported that 600 new cases of ebola were recorded in the worst affected countries in just the past week.

Infection rates appear to be stabilising in Guinea and stabilising or declining in Liberia, but increasing in Sierra Leone, said the WHO.

More on this topic

UN agency condemns Tanzania for not sharing details on Ebola-like casesUN agency condemns Tanzania for not sharing details on Ebola-like cases

Ebola outbreak spreads to new province in DR CongoEbola outbreak spreads to new province in DR Congo

Two Ebola patients ‘cured’ by new drugs in Democratic Republic of CongoTwo Ebola patients ‘cured’ by new drugs in Democratic Republic of Congo

Baby daughter of Ebola victim gets disease as Rwanda closes border with DR CongoBaby daughter of Ebola victim gets disease as Rwanda closes border with DR Congo


Carol O’Callaghan continues her round-up of home interior shops in country towns and the outer reaches of our cities, finding more treasure troves which offer something new and a touch of exclusivityMade in Munster: The best interior shops in country towns

When the Irish Examiner broke the news that an ultra-inquisitive deer photobombed newlyweds at Killarney’s Ladies View the story went viral.Wedding of the Week: Time for Australian celebrations for bride and groom photobombed by deer

At the start of the 10th and final episode of Confronting: OJ Simpson, a series which has been downloaded over five million times since launching in June, host Kim Goldman is in tears, talking to her father about how strong he was through the murder of her brother, his son,Ron Goldman.Podcast Corner: Host relives brother’s death in famous case

Thomas McCarthy pays tribute to his late friend — poet and journalist Seán Dunne'Seán Dunne was one of the most loved people I ever knew'

More From The Irish Examiner